BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19913032)

  • 1. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
    Schoch GA; D'Arcy B; Stihle M; Burger D; Bär D; Benz J; Thoma R; Ruf A
    J Mol Biol; 2010 Jan; 395(3):568-77. PubMed ID: 19913032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
    Kroe RR; Baker MA; Brown MP; Farrow NA; Gautschi E; Hopkins JL; LaFrance RR; Kronkaitis A; Freeman D; Thomson D; Nabozny G; Grygon CA; Labadia ME
    Biophys Chem; 2007 Jul; 128(2-3):156-64. PubMed ID: 17466438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
    Xu HE; Stanley TB; Montana VG; Lambert MH; Shearer BG; Cobb JE; McKee DD; Galardi CM; Plunket KD; Nolte RT; Parks DJ; Moore JT; Kliewer SA; Willson TM; Stimmel JB
    Nature; 2002 Feb; 415(6873):813-7. PubMed ID: 11845213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.
    Frego L; Davidson W
    Protein Sci; 2006 Apr; 15(4):722-30. PubMed ID: 16600964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A; Garside H; Berry A; Waters C; White A; Ray D
    Mol Endocrinol; 2003 May; 17(5):845-59. PubMed ID: 12569182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical probes to identify the glucocorticoid receptor ligands in living cells.
    Awais M; Sato M; Umezawa Y
    Steroids; 2007 Dec; 72(14):949-54. PubMed ID: 17897691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.
    Alvarez LD; Martí MA; Veleiro AS; Presman DM; Estrin DA; Pecci A; Burton G
    J Med Chem; 2008 Mar; 51(5):1352-60. PubMed ID: 18284186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the stability and solubility of the glucocorticoid receptor ligand-binding domain by high-throughput library screening.
    Seitz T; Thoma R; Schoch GA; Stihle M; Benz J; D'Arcy B; Wiget A; Ruf A; Hennig M; Sterner R
    J Mol Biol; 2010 Nov; 403(4):562-77. PubMed ID: 20850457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW; Ruigt GS; Craighead M; Kitchener P
    Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.
    Kauppi B; Jakob C; Färnegårdh M; Yang J; Ahola H; Alarcon M; Calles K; Engström O; Harlan J; Muchmore S; Ramqvist AK; Thorell S; Ohman L; Greer J; Gustafsson JA; Carlstedt-Duke J; Carlquist M
    J Biol Chem; 2003 Jun; 278(25):22748-54. PubMed ID: 12686538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomic structure of progesterone complexed with its receptor.
    Williams SP; Sigler PB
    Nature; 1998 May; 393(6683):392-6. PubMed ID: 9620806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
    Dey R; Roychowdhury P
    J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
    Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
    Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.
    Stanley TB; Leesnitzer LM; Montana VG; Galardi CM; Lambert MH; Holt JA; Xu HE; Moore LB; Blanchard SG; Stimmel JB
    Biochemistry; 2003 Aug; 42(31):9278-87. PubMed ID: 12899614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectroscopic determination of the binding affinity of zinc to the DNA-binding domains of nuclear hormone receptors.
    Payne JC; Rous BW; Tenderholt AL; Godwin HA
    Biochemistry; 2003 Dec; 42(48):14214-24. PubMed ID: 14640689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
    Moretti L; Pentikäinen OT; Settimo L; Johnson MS
    J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based gene expression profiling reveals novel roles of glucocorticoid receptor in cardiac metabolism.
    Yoshikawa N; Nagasaki M; Sano M; Tokudome S; Ueno K; Shimizu N; Imoto S; Miyano S; Suematsu M; Fukuda K; Morimoto C; Tanaka H
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1363-73. PubMed ID: 19293335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
    Li Y; Suino K; Daugherty J; Xu HE
    Mol Cell; 2005 Aug; 19(3):367-80. PubMed ID: 16061183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.